Stock-Based Compensation (Annual)

Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.

Hikma Pharmaceuticals Plc (HKMPF) had Stock-Based Compensation of $23.00M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$3.35B
Net Income	$402.00M
Cost of Goods Sold	$1.91B
Gross Profit	$1.44B
Operating Expenses	$2.81B
Operating Income	$542.00M
Non-Operating Income/Expense	$-23.00M
Pre-Tax Income	$519.00M
Normalized Pre-Tax Income	$518.00M
Income after Taxes	$407.00M
Income from Continuous Operations	$407.00M
Consolidated Net Income/Loss	$407.00M
Normalized Income after Taxes	$405.78M
EBIT	$542.00M
EBITDA	$780.00M
Weighted-Average Shares Outstanding (Basic)	220.59M
Weighted-Average Shares Outstanding (Diluted)	222.68M
Earnings per Share (EPS) (Basic)	$1.82
Earnings per Share (EPS) (Diluted)	$1.81
Balance Sheet Financials
Current Assets	$2.64B
Property, Plant, and Equipment	$1.40B
Long-Term Assets	$3.03B
Total Assets	$5.67B
Current Liabilities	$1.45B
Long-Term Debt	$1.49B
Long-Term Liabilities	$1.61B
Total Liabilities	$3.06B
Common Equity	$2.61B
Tangible Shareholders Equity	$1.44B
Shareholders Equity	$2.61B
Common Shares Outstanding	234.72M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$436.00M
Cash Flow from Investing Activities	$-388.00M
Cash Flow from Financial Activities	$-25.00M
Beginning Cash	$188.00M
End Cash	$217.00M
Increase/Decrease in Cash	$29.00M
Stock-Based Compensation	$23.00M
Common Stock Dividends Paid	$-188.00M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.82
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.36
Debt to Equity Ratio	0.62
Gross Margin	43.03%
Operating Margin	16.18%
EBIT Margin	16.18%
EBITDA Margin	23.29%
Pre-Tax Profit Margin	15.50%
Profit Margin	12.00%
Free Cash Flow	$239.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.59
Inventory Turnover	1.73
Receiveable Turnover	3.10
Days Sales in Receivables	117.60
Return on Equity	15.62%
Return on Tangible Equity	28.34%
Return on Assets	7.18%
Return on Investments	9.94%
Book Value Per Share	$11.10
Free Cash Flow per Share	$1.07
Operating Cash Flow per Share	$1.96

Data from Zacks Investment Research, Inc.